Kimura et al. [36] found that MYL9 is a ligand of CD69 and that the expression of CD69 is linked to the MYL9 network to control the depletion state of tumor-infiltrated T cells and enhance antitumor immunity. This evidence concerns the gene CD69 and neoplasm.